サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1518765

バイオプロセスモニタリングの世界市場：2024-2031年

Global Bioprocess Monitoring Market 2024-2031
出版日: | 発行: Orion Market Research | ページ情報: 英文 145 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
バイオプロセスモニタリングの世界市場：2024-2031年
出版日: 2024年06月23日
発行: Orion Market Research
ページ情報: 英文 145 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオプロセスモニタリング市場は予測期間（2024-2031年）にCAGR 8.4％で成長すると予測されます。バイオプロセスモニタリングとは、生物学的産物の生産に最適な条件を確保するために、バイオプロセス中の様々なパラメータを系統的に観察、測定、制御することを指します。市場成長の大部分は、バイオ医薬品とバイオテクノロジープロセスの採用が拡大していることに起因しています。その結果、より信頼性が高く正確なバイオプロセスモニタリング機器に対するニーズが高まっています。

市場力学

バイオ医薬品需要の高まりがバイオプロセスモニタリングの成長を牽引

慢性疾患、がん、感染症に対する効果的な治療に対するニーズの高まりにより、バイオ医薬品に対する需要は急速に増加しています。モノクローナル抗体、ワクチン、細胞療法などのバイオ医薬品は、標的を絞った個別化治療の選択肢を提供し、従来の医薬品よりもますます好まれるようになっています。世界人口の高齢化とこれらの疾患の有病率の上昇に伴い、バイオ医薬品産業は拡大しています。この拡大により、市場の需要に対応するため、厳しい規制基準に従ってバイオ医薬品製品の品質、有効性、安全性を確保するための強固なバイオプロセスモニタリングが必要となっています。

バイオプロセスモニタリングの情勢を形成する技術の進歩

技術の進歩がバイオプロセスモニタリング市場に革命をもたらしています。センサー技術、リアルタイムモニタリングシステム、データ分析における革新は、バイオプロセスの精度と効率を高めています。自動化と高度な制御システムにより、バイオプロセスのパラメーターの継続的なモニタリングと最適化が可能になり、製品の品質と収率の向上につながります。さらに、バイオプロセスのモニタリングに人工知能と機械学習を統合することで、予測的な洞察と高度な分析が可能になり、生産プロセスがさらに最適化されます。このような技術的躍進は、現代のバイオ医薬品製造の複雑な要件を満たす上で極めて重要であり、業界全体で高度なバイオプロセスモニタリングソリューションの採用を促進しています。

市場セグメンテーション

  • 製品別では、市場は試薬・キット、機器、ソフトウェアに区分されます。
  • 用途別では、市場は宿主細胞残存DNA/タンパク質定量、マイコプラズマ検出、ウイルス力価測定、不顕性ウイルス検査に区分されます。
  • 最終用途に基づくと、市場は製薬・バイオテクノロジー企業、CRO・CMO、学術・研究機関に区分されます。

試薬・キットが最大セグメントとして台頭予測

試薬・キットセグメントは市場で最大のシェアを占めると予想されています。このセグメントの成長を支える主な要因としては、バイオ医薬品と個別化医療に対する需要の増加が挙げられます。ワクチン、モノクローナル抗体、遺伝子治療などの生物製剤の開発・生産が増加の一途をたどる中、精密で信頼性の高いバイオプロセス監視ツールの必要性が高まっています。試薬やキットは、これらのバイオ医薬品の品質、有効性、安全性を確保するために不可欠であり、市場での需要を牽引しています。

医薬品・バイオテクノロジーセグメントが大きな市場シェアを占める

製薬・バイオテクノロジーセグメントは、ワクチンや遺伝子治療など、品質と有効性の正確なモニタリングを必要とするバイオ医薬品に対する需要の高まりにより、大きな市場シェアを占めています。技術の進歩、厳格な規制遵守、多額の研究開発投資が、高度なモニタリングソリューションの採用をさらに後押ししています。さらに、バイオテクノロジー新興企業の成長と個別化医療へのシフトは、洗練されたバイオプロセスモニタリングツールの必要性を高め、市場におけるこの分野の重要性を確固たるものにしています。

地域別展望

世界のバイオプロセスモニタリング市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋（インド、中国、日本、韓国、その他アジア太平洋地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらに細分化されています。

アジア太平洋：バイオプロセスモニタリング市場急成長のマーケットカタリスト

アジア太平洋地域は、医療費の増大と患者数の増加に牽引されるバイオ医薬品産業により、高度なバイオプロセスモニタリング技術への需要が高まっており、また、中国、インド、韓国などの国々のバイオテクノロジーやライフサイエンス分野への支援的な政府の取り組みや投資が、バイオプロセスモニタリングソリューションの技術革新と開発を促進しているため、急成長市場として浮上しています。さらに、アジア太平洋諸国への医薬品製造のアウトソーシングは、コストメリットと熟練した労働力により、同地域の市場成長をさらに後押ししています。

北米が主要市場シェアを占める

全地域の中で北米が大きなシェアを占めているのは、バイオ医薬品産業が堅調で成熟しており、大手企業が研究開発に多額の投資を行っているため、最先端のバイオプロセスモニタリング技術に対する需要が高まっているためです。第二に、北米にはバイオテクノロジー企業や製薬企業が密集しており、特に米国などの主要拠点に集中しています。これらの企業は技術革新と効率性を最優先しており、競争力を維持し、FDAなどの機関が定める厳しい規制基準を遵守するために、高度なバイオプロセスモニタリング・ソリューションが必要とされています。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主要市場動向
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Bio-Rad Laboratories, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • GE HealthCare
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Thermo Fisher Scientific Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • バイオプロセスモニタリングの世界市場：製品別
    • 試薬・キット
    • 機器
    • ソフトウェア
  • バイオプロセスモニタリングの世界市場：用途別
    • 宿主細胞残留DNA/タンパク質定量
    • マイコプラズマ検出
    • ウイルス力価測定
    • 不顕性ウイルス検査
  • バイオプロセスモニタリングの世界市場：最終用途別
    • 製薬・バイオテクノロジー企業
    • CRO・CMO
    • 学術・研究機関

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第6章 企業プロファイル

  • Applied Biological Materials Inc.
  • Bio-Techne
  • Boehringer Ingelheim
  • Charles River Laboratories
  • Corning Incorporated
  • DH Life Sciences, LLC
  • Enzo Life Sciences, Inc.
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Hamilton Company
  • Lonza Group Ltd.
  • Maravai LifeSciences
  • Meissner Filtration Products, Inc.
  • Merck KGaA
  • QIAGEN
  • Sartorius AG
図表

LIST OF TABLES

  • 1. Global Bioprocess Monitoring Market Research And Analysis By Product, 2023-2031 ($ Million)
  • 2. Global Bioprocess Monitoring Reagents & Kits Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 3. Global Bioprocess Monitoring Instruments Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 4. Global Bioprocess Monitoring Software Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 5. Global Bioprocess Monitoring Market Research And Analysis By Application, 2023-2031 ($ Million)
  • 6. Global Bioprocess Monitoring For Host Cell Residual DNA/Protein Quantitation Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 7. Global Bioprocess Monitoring For Mycoplasma Detection Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 8. Global Bioprocess Monitoring For Viral Titer Determination Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 9. Global Bioprocess Monitoring For Adventitious Virus Testing Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 10. Global Bioprocess Monitoring Market Research And Analysis By End-Use, 2023-2031 ($ Million)
  • 11. Global Bioprocess Monitoring In Pharmaceutical & Biotechnology Companies Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 12. Global Bioprocess Monitoring In CROs & CMOS Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 13. Global Bioprocess Monitoring In Academic & Research Institutes Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 14. Global Bioprocess Monitoring Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 15. North American Bioprocess Monitoring Market Research And Analysis By Country, 2023-2031 ($ Million)
  • 16. North American Bioprocess Monitoring Market Research And Analysis By Product, 2023-2031 ($ Million)
  • 17. North American Bioprocess Monitoring Market Research And Analysis By Application, 2023-2031 ($ Million)
  • 18. North American Bioprocess Monitoring Market Research And Analysis By End-Use, 2023-2031 ($ Million)
  • 19. European Bioprocess Monitoring Market Research And Analysis By Country, 2023-2031 ($ Million)
  • 20. European Bioprocess Monitoring Market Research And Analysis By Product, 2023-2031 ($ Million)
  • 21. European Bioprocess Monitoring Market Research And Analysis By Application, 2023-2031 ($ Million)
  • 22. European Bioprocess Monitoring Market Research And Analysis By End-Use, 2023-2031 ($ Million)
  • 23. Asia-Pacific Bioprocess Monitoring Market Research And Analysis By Country, 2023-2031 ($ Million)
  • 24. Asia-Pacific Bioprocess Monitoring Market Research And Analysis By Product, 2023-2031 ($ Million)
  • 25. Asia-Pacific Bioprocess Monitoring Market Research And Analysis By Application, 2023-2031 ($ Million)
  • 26. Asia-Pacific Bioprocess Monitoring Market Research And Analysis By End-Use, 2023-2031 ($ Million)
  • 27. Rest Of The World Bioprocess Monitoring Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 28. Rest Of The World Bioprocess Monitoring Market Research And Analysis By Product, 2023-2031 ($ Million)
  • 29. Rest Of The World Bioprocess Monitoring Market Research And Analysis By Application, 2023-2031 ($ Million)
  • 30. Rest Of The World Bioprocess Monitoring Market Research And Analysis By End-Use, 2023-2031 ($ Million)

LIST OF FIGURES

  • 1. Global Bioprocess Monitoring Market Share By Product, 2023 Vs 2031 (%)
  • 2. Global Bioprocess Monitoring Reagents & Kits Market Share By Region, 2023 Vs 2031 (%)
  • 3. Global Bioprocess Monitoring Instruments Market Share By Region, 2023 Vs 2031 (%)
  • 4. Global Bioprocess Monitoring Software Market Share By Region, 2023 Vs 2031 (%)
  • 5. Global Bioprocess Monitoring Market Share By Application, 2023 Vs 2031 (%)
  • 6. Global Bioprocess Monitoring For Host Cell Residual DNA/Protein Quantitation Market Share By Region, 2023 Vs 2031 (%)
  • 7. Global Bioprocess Monitoring For Mycoplasma Detection Market Share By Region, 2023 Vs 2031 (%)
  • 8. Global Bioprocess Monitoring For Viral Titer Determination Market Share By Region, 2023 Vs 2031 (%)
  • 9. Global Bioprocess Monitoring For Adventitious Virus Testing Market Share By Region, 2023 Vs 2031 (%)
  • 10. Global Bioprocess Monitoring Market Share By End-Use, 2023 Vs 2031 (%)
  • 11. Global Bioprocess Monitoring In Pharmaceutical & Biotechnology Companies Market Share By Region, 2023 Vs 2031 (%)
  • 12. Global Bioprocess Monitoring In CROs & CMOS Market Share By Region, 2023 Vs 2031 (%)
  • 13. Global Bioprocess Monitoring In Academic & Research Institutes Market Share By Region, 2023 Vs 2031 (%)
  • 14. Global Bioprocess Monitoring Market Share By Region, 2023 Vs 2031 (%)
  • 15. US Bioprocess Monitoring Market Size, 2023-2031 ($ Million)
  • 16. Canada Bioprocess Monitoring Market Size, 2023-2031 ($ Million)
  • 17. UK Bioprocess Monitoring Market Size, 2023-2031 ($ Million)
  • 18. France Bioprocess Monitoring Market Size, 2023-2031 ($ Million)
  • 19. Germany Bioprocess Monitoring Market Size, 2023-2031 ($ Million)
  • 20. Italy Bioprocess Monitoring Market Size, 2023-2031 ($ Million)
  • 21. Spain Bioprocess Monitoring Market Size, 2023-2031 ($ Million)
  • 22. Rest Of Europe Bioprocess Monitoring Market Size, 2023-2031 ($ Million)
  • 23. India Bioprocess Monitoring Market Size, 2023-2031 ($ Million)
  • 24. China Bioprocess Monitoring Market Size, 2023-2031 ($ Million)
  • 25. Japan Bioprocess Monitoring Market Size, 2023-2031 ($ Million)
  • 26. South Korea Bioprocess Monitoring Market Size, 2023-2031 ($ Million)
  • 27. Rest Of Asia-Pacific Bioprocess Monitoring Market Size, 2023-2031 ($ Million)
  • 28. Latin America Bioprocess Monitoring Market Size, 2023-2031 ($ Million)
  • 29. Middle East And Africa Bioprocess Monitoring Market Size, 2023-2031 ($ Million)
目次
Product Code: OMR2028679

Bioprocess Monitoring Market Size, Share & Trends Analysis Report by Product (Reagents & Kits, Instruments and Software), by Application (Host Cell Residual DNA/Protein Quantitation, Mycoplasma Detection, Viral Titer Determination, and Adventitious Virus Testing), and by End-Use (Pharmaceutical & Biotechnology Companies, CROs & CMOs, and Academic & Research Institutes), Forecast Period (2024-2031)

Bioprocess monitoring market is anticipated to grow at a CAGR of 8.4% during the forecast period (2024-2031). Bioprocess monitoring refers to the systematic observation, measurement, and control of various parameters during a bioprocess to ensure optimal conditions for the production of biological products. The market growth is attributed in large part to the growing adoption of biopharmaceuticals and biotechnology processes. As a result, there is a growing need for more reliable and accurate bioprocess monitoring instruments.

Market Dynamics

Rising Demand for Biopharmaceuticals Driving Growth in Bioprocess Monitoring

The demand for biopharmaceuticals is rapidly increasing, driven by the growing need for effective treatments for chronic diseases, cancer, and infectious diseases. Biopharmaceuticals, such as monoclonal antibodies, vaccines, and cell therapies, offer targeted and personalized treatment options, which are increasingly preferred over traditional pharmaceuticals. As the global population ages and the prevalence of these conditions rises, the biopharmaceutical industry is expanding. This expansion necessitates robust bioprocess monitoring to ensure the quality, efficacy, and safety of biopharmaceutical products with stringent regulatory standards to meet market demands.

Technological Advancements Reshaping the Bioprocess Monitoring Landscape

Technological advancements are revolutionizing the bioprocess monitoring market. Innovations in sensor technologies, real-time monitoring systems, and data analytics are enhancing the precision and efficiency of bioprocesses. Automation and advanced control systems enable continuous monitoring and optimization of bioprocess parameters, leading to improved product quality and yield. Additionally, the integration of artificial intelligence and machine learning in bioprocess monitoring provides predictive insights and advanced analytics, further optimizing production processes. These technological breakthroughs are crucial in meeting the complex requirements of modern biopharmaceutical manufacturing, driving the adoption of advanced bioprocess monitoring solutions across the industry. For instance, in October 2022, Cambridge Molecular Diagnostics Limited introduced a new lateral flow test engineered for the swift detection of Mycoplasma contamination. This pioneering test offers rapid and user-friendly applications, providing precise results within minutes. It employs an enhanced PCR methodology.

Market Segmentation

  • Based on product, the market is segmented into reagents & kits, instruments, and software.
  • Based on application, the market is segmented into host cell residual DNA/protein quantitation, mycoplasma detection, viral titer determination, and adventitious virus testing.
  • Based on end-use, the market is segmented into pharmaceutical & biotechnology companies, CROs & CMOs, and academic & research institutes.

Reagents & Kits is Projected to Emerge as the Largest Segment

The reagents & kits segment is expected to hold the largest share of the market. The primary factor supporting the segment's growth includes the increasing demand for biopharmaceuticals and personalized medicine. As the development and production of biologics, such as vaccines, monoclonal antibodies, and gene therapies, continue to rise, there is a growing need for precise and reliable bioprocess monitoring tools. Reagents and kits are essential for ensuring the quality, efficacy, and safety of these biopharmaceutical products, driving their demand in the market. For instance, in July 2022, QIAGEN, a leading supplier of testing technology and materials, expanded its QIAcuity PCR portfolio by introducing 13 new kits and assays These state-of-the-art instruments simplify the quantification of residual host cell DNA within cells and enhance the accuracy of viral titer measurement for the Adeno-Associated Virus.

Pharmaceutical & Biotechnology Segment to Hold a Considerable Market Share

The pharmaceutical & biotechnology segment holds a significant market share due to the rising demand for biopharmaceuticals, such as vaccines and gene therapies, which require precise monitoring for quality and efficacy. Technological advancements, stringent regulatory compliance, and substantial R&D investments further drive the adoption of advanced monitoring solutions. Additionally, the growth of biotech startups and the shift towards personalized medicine increase the need for sophisticated bioprocess monitoring tools, solidifying the importance of this segment in the market.

Regional Outlook

The global bioprocess monitoring market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Asia-Pacific: A Catalyst for Rapid Growth in the Bioprocess Monitoring Market

Asia-Pacific emerges as the fastest-growing market due to the biopharmaceutical industry, driven by increasing healthcare expenditures and a growing patient population, fuels the demand for advanced bioprocess monitoring technologies and also the supportive government initiatives and investments in biotechnology and life sciences sectors across countries like China, India, and South Korea foster innovation and development in bioprocess monitoring solutions. Additionally, the outsourcing of pharmaceutical manufacturing to Asia-Pacific countries, owing to cost advantages and a skilled workforce, further propels market growth in the region. For instance, in November 2023, Asahi Kasei Medical unveiled the Asahi Kasei (China) Bioprocess Technical Center in Jiangsu, China, marking its official inauguration. As an integral part of Asahi Kasei Medical's bioprocess division, the center is dedicated to providing an extensive array of offerings encompassing bioprocessing, including biotherapeutic manufacturing, biosafety testing, and contract development and manufacturing organization (CDMO) services.

North America Holds Major Market Share

Among all the regions, North America holds a significant share due to a robust and mature biopharmaceutical industry, with leading companies investing significantly in research and development, driving the demand for cutting-edge bioprocess monitoring technologies. Secondly, North America is home to a dense concentration of biotechnology and pharmaceutical companies, particularly in key hubs like the US. These companies prioritize innovation and efficiency, necessitating advanced bioprocess monitoring solutions to maintain competitiveness and compliance with stringent regulatory standards set by agencies like the FDA. For instance, in July 2021, Cygnus Technologies, a division of Maravai LifeSciences, and Gyros Protein Technologies, a Swedish leader in automated nanoliter-scale immunoassays, disclosed an expansion of their partnership. A significant milestone in their collaborative endeavors was marked by the release of an upgraded HEK 293 HCP immunoassay solution, a direct outcome of their joint efforts.

Market Players Outlook

The major companies serving the global bioprocess monitoring market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Maravai LifeSciences, Merck KGaA, and Bio-Techne, among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers and acquisitions to stay competitive in the market. For instance, in October 2023, the US Pharmacopeia (USP) and the American Type Culture Collection (ATCC) formed a strategic alliance aimed at advancing quality control measures for vaccines and biological medicines. This partnership has resulted in the introduction of six innovative products designed to improve the identification and measurement of residual host cell DNA, enhancing the overall quality assurance processes in the biopharmaceutical industry.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Market Trends
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Bio-Rad Laboratories, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. GE HealthCare
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Thermo Fisher Scientific Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Bioprocess Monitoring Market by Product
    • 4.1.1. Reagents & Kits
    • 4.1.2. Instruments
    • 4.1.3. Software
  • 4.2. Global Bioprocess Monitoring Market by Application
    • 4.2.1. Host Cell Residual DNA/Protein Quantitation
    • 4.2.2. Mycoplasma Detection
    • 4.2.3. Viral Titer Determination
    • 4.2.4. Adventitious Virus Testing
  • 4.3. Global Bioprocess Monitoring Market by End-Use
    • 4.3.1. Pharmaceutical & Biotechnology Companies
    • 4.3.2. CROs & CMOs
    • 4.3.3. Academic & Research Institutes

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World
    • 5.4.1. Latin America
    • 5.4.2. Middle East & Africa

6. Company Profiles

  • 6.1. Applied Biological Materials Inc.
  • 6.2. Bio-Techne
  • 6.3. Boehringer Ingelheim
  • 6.4. Charles River Laboratories
  • 6.5. Corning Incorporated
  • 6.6. DH Life Sciences, LLC
  • 6.7. Enzo Life Sciences, Inc.
  • 6.8. Eppendorf SE
  • 6.9. F. Hoffmann-La Roche Ltd.
  • 6.10. GE Healthcare
  • 6.11. Hamilton Company
  • 6.12. Lonza Group Ltd.
  • 6.13. Maravai LifeSciences
  • 6.14. Meissner Filtration Products, Inc.
  • 6.15. Merck KGaA
  • 6.16. QIAGEN
  • 6.17. Sartorius AG